ISMP home page Support ISMP ISMP Newsletters ISMP Teleconferences ISMP Online Forums Report a medication error to ISMP Educational programs ISMP online store ISMP consulting services FAQ About ISMP Contact ISMP
 

Updated: ISMP's List of High-Alert Medications

Click here for printer friendly version

From the August 9, 2007 issue

Based on a 2007 practitioner survey and review by ISMP and other medication safety experts, ISMP’s List of High-Alert Medications has been updated (see the PDF version of the newsletter for a list). Additions to the list include: epoprostenol (Flolan) IV, oxytocin IV, promethazine IV, and sterile water for injection, inhalation, and irrigation (excluding pour bottles) in containers of 100 mL or more. Warfarin, heparin, low-molecular-weight heparin, thrombolytics, and glycoprotein IIb/IIIa inhibitors were moved to a new category, antithrombotic agents, to which Factor Xa inhibitors and direct thrombin inhibitors were added. Amiodarone and lidocaine were also moved to a new category, anti-arrhythmics IV. Nesiritide was removed from the list due to a significant decline in use.

Click here to to see the list.

Resources
Acute Care Main Page
Current Issue
Past Issues
Recent articles
Survey Results
Action Agendas - Free CE's
Hazard Alerts
Subscribe
Contest Winners
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Consumer
Institute for Safe Medication Practices
200 Lakeside Drive, Suite 200
Horsham, PA 19044
215-947-7797, fax 215-914-1492